HANARO MSCI VIROLOGYHANARO MSCI VIROLOGYHANARO MSCI VIROLOGY

HANARO MSCI VIROLOGY

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪1.60 B‬KRW
Fund flows (1Y)
‪−3.90 B‬KRW
Dividend yield (indicated)
1.34%
Discount/Premium to NAV
−0.2%
Shares outstanding
‪150.00 K‬
Expense ratio
0.50%

About HANARO MSCI VIROLOGY


Brand
Amundi
Home page
Inception date
Jun 8, 2022
Index tracked
MSCI World IMI Virology Select Index - KRW - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
NH-Amundi Asset Management Co., Ltd.
ISIN
KR7432850006

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Vanilla
Geography
Developed Markets
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of April 29, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Cash
Stocks74.39%
Health Technology74.39%
Bonds, Cash & Other25.61%
Cash25.61%
Stock breakdown by region
69%30%
North America69.74%
Europe30.26%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows